Genetic alteration of the D2 domain abolishes von Willebrand factor multimerization and trafficking into storage

S L Haberichter1, A M Allmann, M A Jozwiak

  • 1Department of Pediatrics, Medical College of Wisconsin, and Children's Research Institute, Children's Hospital of Wisconsin, Milwaukee, WI 53226, USA. shaberic@mcw.edu

Abstract

Insights

A mutation in the von Willebrand factor (VWF) propeptide causes defects in VWF processing and storage. Surprisingly, normal VWF can partially restore function in trans, suggesting a broader role for VWFpp.

Area of Science:

  • Hematology
  • Molecular Biology
  • Protein Biochemistry

Background:

  • The von Willebrand factor (VWF) propeptide (VWFpp) is crucial for mature VWF protein multimerization and storage.
  • Mutations affecting VWF multimerization are known in von Willebrand disease, but their impact on VWF regulated storage is less understood.

Purpose of the Study:

  • To investigate the functional consequences of a specific VWF gene mutation on VWF processing, multimerization, and storage.
  • To explore the role of VWFpp in the regulated storage of VWF.

Main Methods:

  • Identified a heterozygous in-frame deletion in exon 12 of the VWF gene, leading to the loss of amino acids 436-442 in VWFpp.
  • Utilized expression studies to analyze the secretion, multimerization, and storage of the variant VWF.

Main Results:

  • The identified VWF variant exhibited reduced secretion, loss of VWF multimerization, and defective regulated storage.
  • Defective storage was linked to impaired propeptide storage due to a faulty sorting signal on VWFpp.
  • Coexpression of wild-type VWF or VWFpp partially restored multimerization of the variant VWF in trans.

Conclusions:

  • A six-amino acid deletion in VWFpp causes significant defects in VWF processing, storage, and overall function.
  • VWFpp can influence VWF multimerization from a variant allele in trans, indicating a potential non-homotypic function.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...